Miguel Chuquilin, MD

Miguel.chuquilin@neurology.ufl.edu

Dr. Chuquilin received his medical degree from the Universidad Peruana Cayetano Heredia in Lima, Peru in 2003. He completed his neurology residency in 2010 and neuromuscular medicine and EMG fellowship at Washington University in St. Louis, MO in 2011. He then joined the Faculty at the University of Missouri in Columbia as Assistant Professor of Neurology in 2011. He served as the multidisciplinary MU ALS treatment center Director at the ALS clinic which opened in 2015. He also attended the Muscular Dystrophy Association clinic at the University of Missouri in Columbia. He joined the Faculty at the University of Florida in 2016.

Dr. Chuquilin is board certified in neurology (ABPN), neuromuscular medicine (ABPN) and electrodiagnostic medicine (AANEM). He is also a member of the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Electrodiagnostic Self-Assessment Examination (SAE) Committee since 2015.

Dr. Chuquilin performs Botulinum toxin injection for migraine prophylaxis, occipital nerve blocks and skin biopsies to evaluate for small fiber neuropathy.

Clinical Interests

Neuromuscular junction disorders
Autonomic disorders
Motor neuron disease
Myopathies
Muscle and nerve biopsy
General neurology

Awards and Recognitions

2002     Medical School Class Valedictorian. Cayetano Heredia Peruvian University.  Lima, Peru.
2010     Resident Scholarship to the AAN Annual Meeting.

Medical Education

Cayetano Heredia Peruvian University, Lima, Peru, 2003

Internship

Internal Medicine – Washington University, St. Louis, MO 2007

Residency

Neurology – Washington University, St. Louis, MO 2009

Fellowship

Neuromuscular Medicine – Washington University, St Louis, MO 2011

Professional Societies

American Academy of Neurology, 2010
American Association of Neuromuscular and Electrodiagnostic Medicine, 2012

Selected Publications

Chuquilin M, Govindarajan R, Peck D, Font-Montgomery E. Response to letter to the editor: Why does Leigh syndrome respond to immunotherapy?.  Mol Gen Metab Reports 2016; 8: 85-86. DOI:10.1016/j.ymgmr.2016.08.003.

Kuruvilla M, Isabelle A, Chuquilin M. Effects of clear speech on articulatory kinematics in talkers with ALS. Int J Speech-Language Path. Submitted July 2016.

Perugula M, Uppal G, Chuquilin M. Acute demyelinating polyneuropathy as presentation of hereditary neuropathy with liability to pressure palsies in a patient that exercised regularly in the Army. J Clin Neuromusc Dis, accepted for publication July 2016.

Chuquilin M, Govindarajan R, Peck D, Font-Montgomery E. Response to immunotherapy in a patient with adult onset Leigh syndrome and T9176C mtDNA mutation. Mol Gen Metab Reports 2016; 8:28-32. DOI: 10.1016/j.ymgmr.2016.06.004.

Chuquilin M. Persistent nasal speech in a myasthenia gravis patient. Neurol Clin Pract (published online March 21, 2016),DOI:10.1212/CPJ.0000000000000246.

For a complete list of publications click here.